Efficacy and Safety of Ipilimumab Plus Anti-PD-1/PD-L1 Antibodies Combination Therapy in Advanced Hepatocellular Carcinoma Patients Progressing After Multiple Lines of Treatment: A Retrospective Multicenter Study

Su-Su Zheng,1 Jing-Fang Wu,1 Zhen-Zhen Zhang,1 Yan-Fang Wu,1 Yi-Jie Chen,2 Sheng Qian,3 Bo-Heng Zhang1,4,5 1Department of Hepatic Oncology, Xiamen Clinical Research Center for Cancer Therapy, Clinical Research Center for Precision medicine of Abdominal Tumor of Fujian Province, Zhongshan Hospital, F...

Full description

Bibliographic Details

Published in:	Journal of Hepatocellular Carcinoma
Main Authors:	Zheng SS, Wu JF, Zhang ZZ, Wu YF, Chen YJ, Qian S, Zhang BH
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-03-01
Subjects:	advanced hepatocellular carcinoma nivolumab ipilimumab immune checkpoint inhibitor retrospective study
Online Access:	https://www.dovepress.com/efficacy-and-safety-of-ipilimumab-plus-anti-pd-1pd-l1-antibodies-combi-peer-reviewed-fulltext-article-JHC